Press Releases

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)-- SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it filed its Annual Report on Form 10-K for Fiscal Year 2024, ended March 31, 2024, with the U.S. Securities and Exchange Commission. It is available on Logitech's website at http://ir.logitech.com.

Logitech expects to publish its annual report to shareholders, and its... (continue reading...)

MONTRÉAL, May 16, 2024 /PRNewswire/ - Bell Canada (Bell) today announced the filing of a prospectus supplement to a short form base shelf prospectus dated May 9, 2024 with the various securities regulatory authorities in all provinces of Canada to renew Bell's MTN program.

The MTN program will enable Bell to offer MTN Debentures from time to time until June 9, 2026. The MTN Debentures will be fully and unconditionally guaranteed by BCE Inc. (TSX, NYSE: BCE).... (continue reading...)

First quarter revenue grew 33% year-over-year to $125 million

Net loss driven entirely by one-time items; Company delivers increased non-GAAP profitability year-over-year excluding one-time items

BETHESDA, Md., May 16, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines”, “ILE”, or “the Company”), a leader in AI-powered learning automation and information intelligence for corporate and educational use, today announced... (continue reading...)

AT&T held its annual stockholder meeting. Additional information can be found on the AT&T Investor Relations website.

Key Takeaways:

• AT&T held its annual stockholder meeting on May 16.
• Each of the 11 nominees to the board of directors were re-elected to a one-year term.
• Once final voting results are available, they will be filed with the SEC and posted on the AT&T Investor Relations website and on AT&T's proxy website.

DALLAS, May 16, 2024 /PRNewswire/ -- AT&T... (continue reading...)

CHICAGO, May 16, 2024 (GLOBE NEWSWIRE) -- Today, the Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, takes a bold step forward in addressing health disparities by announcing the launch of the Coalition for Clinical Trial Equity as part of their latest phase of the Ignore No More Initiative, ACTe Now!: Roadmap 2 Progress. This initiative aims to... (continue reading...)